Guo-yu Hu, Chao-hui Yuan, Kui Tan, and Zhen-zhen Chen. Atypical Chronic Myeloid Leukaemia with Trisomy 13: a Case Report[J].Chinese Medical Sciences Journal, 2011, 26(4): 254-256.
Hall J, Foucar K. Diagnosing myelodysplastic/myelopro- liferative neoplasms: laboratory testing strategies to exclude other disorders. Int J Lab Hematol 2010; 32:559- 71.
2.
Xubo G, Xingguo L, Xianguo W, et al. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia. Eur J Haematol 2009; 83:292- 301.
3.
Hernández JM, del Cañizo MC, Cuneo A, et al. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol 2000; 11:441-4.
4.
Fehniger TA, Byrd JC, Marcucci G, et al. Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13. Blood 2009; 113:1002-5.
Trivedi PJ, Patel PS, Brahmbhatt MM, et al. A new recurring chromosome 13 abnormality in two older patients with de novo acute myeloid leukemia: an Indian experience. Indian J Hum Genet 2009; 15:137-9.
7.
Saigo K, Nakagawa T, Ryo R, et al. Philadelphia chro-mosome-negative chronic myelogenous leukemia with trisomy 13. Rinsho Ketsueki 1995; 36:1295-9.
8.
Ito Y, Hakoda Y, Iwase O, et al. First Japanese case of sole trisomy 13 anomaly in acute myeloid leukemia. Cancer Genet Cytogenet 2000; 120:85-6.